Researchers develop novel test that screens for SARS-CoV-2 variants of concern
A team of scientists from the United States has recently developed a single-tube duplex molecular assay for rapid detection of […]
A team of scientists from the United States has recently developed a single-tube duplex molecular assay for rapid detection of […] The ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen, has claimed […] With over 127.8 million cases of coronavirus disease 2019 (COVID-19) already documented, and many more millions that have undoubtedly gone […] An international team of researchers examined the antibodies from a large cohort of COVID-19 patients. Due to the way antibodies […] Acriflavine is traditionally employed as a topical antiseptic, though has more recently been implicated as an antiviral agent at low […] The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread globally, with […] The heterogeneous coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in Wuhan, […] Nanomedicine is a very powerful tool with the potential to mitigate the burden of disease by providing nanoparticle-based carriers and […] COVID-19 (coronavirus disease 2019) is caused by a new positive-strand RNA coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), […]Sars-CoV-2
Researchers develop novel test that screens for SARS-CoV-2 variants of concern
Long-COVID-19 is a significant risk in recovered patients post-hospitalization
Proper choice of control group nullifies most observed genetic markers for severe COVID-19, study suggests
New targets for antibodies in the fight against SARS-CoV-2
Researchers examine acriflavine's antiviral potential against SARS-CoV-2
Scientists explore structure of SARS-CoV-2 receptor-binding domain with G485R mutation
Living with a COVID-19 case brings worse symptoms and stronger antibody response
The role of nanotechnology in the fight against COVID-19
Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2